In bladder cancer, the use of PHDs was associated with increased risk among individuals with the NAT2 slow acetylation genotype and those lacking the protective NAT1∗10. It may be beneficial to incorporate genetic screening for patients with significant or long-term hair dye exposure. The gene discussed is NAT2; the disease is urinary bladder carcinoma.